Podstawowe statystyki
| LEI | 549300CP8NY40UP89Q40 |
| CIK | 1019600 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Future Metals NL
SEC Filings (Chronological Order)
Na tej stronie znajduje się pełna, chronologiczna lista zgłoszeń SEC, z wyłączeniem zgłoszeń własności, które udostępniamy gdzie indziej.
| February 14, 2012 |
DE:FME / Fresenius Medical Care AG & Co KGaA / FMR LLC Passive Investment SCHEDULE 13G Amendment No. 1 Fresenius Medical Care AG Common Stock Cusip #D2734Z107 Cusip #D2734Z107 Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 4,666,892 Item 6: 0 Item 7: 9,701,042 Item 8: 0 Item 9: 9,701,042 Item 11: 3.234% Item 12: HC Cusip #D2734Z107 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 9,701,042 Item 8: |
|
| February 14, 2011 |
SCHEDULE 13G Amendment No. 0 Fresenius Medical Care AG Common Stock Cusip #D2734Z107 Cusip #D2734Z107 Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 8,933,878 Item 6: 0 Item 7: 15,860,903 Item 8: 0 Item 9: 15,860,903 Item 11: 5.317% Item 12: HC Cusip #D2734Z107 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 15,860,903 Item |
|
| June 2, 2008 | ||
| June 2, 2008 | ||
| May 3, 2006 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2006 FRESENIUS MEDICAL CARE AG & Co. KGaA (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| May 3, 2006 |
Fresenius Medical Care Reports First Quarter 2006 Results; Excellent Start into the Year 2006 Exhibit 99.1 Investor News Fresenius Medical Care AG & Co. KGaA Investor Relations Else-Kröner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail : [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 3, 2006 Fresenius Medical Care Reports |
|
| February 21, 2006 |
Via Facsimile Mail Stop 03-09 February 21, 2006 Dr. Ben J. Lipps Chief Executive Officer 95 Hayden Avenue Lexington, MA 02420 Re: Fresenius Medical Care Corporation Form 20-F for the fiscal year ended December 31, 2004 File No. 1-14444 Dear Dr. Lipps: We have completed our review of your Form 20-F and related filings and have no further comments at this time. Sincerely, Jim B. Rosenberg Senior Ass |
|
| February 13, 2006 |
EXHIBIT 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG & Co. KGaA Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| February 13, 2006 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2006 FRESENIUS MEDICAL CARE AG & Co. KOMMANDITGESELLSCHAFT AUF AKTIEN - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive |
|
| February 9, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, iss |
|
| February 8, 2006 |
EXHIBIT 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com - February |
|
| February 8, 2006 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2006 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check ma |
|
| February 1, 2006 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2006 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check ma |
|
| February 1, 2006 |
EXHIBIT 99.1 [GRAPHIC OMITTED] Fresenius Medical Care PRESS RELEASE Contact: Contact: Oliver Maier Heinz Schmidt Sr. V.P. Investor Relations & Communications Vice President Investor Relations Phone: + 49 6172 609 2601 Phone: 1- 781 402 4518 Fax: + 49 6172 609 2301 Fax: 1- 781 402 9741 E-mail: [email protected] E-mail: [email protected] Internet: http://www.fmc-ag.com Fresenius Medical Care North |
|
| January 26, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, iss |
|
| January 26, 2006 |
Filed pursuant to Rule 424(b)(3) Registration No. 333-128899 FRESENIUS MEDICAL CARE AG FRESENIUS MEDICAL CARE AG & Co. KGaA SUPPLEMENT DATED JANUARY 26 2006 TO PROSPECTUS DATED JANUARY 4, 2006 On January 5, 2006, we resolved to offer additional options to acquire up to 508,000 preference shares under our 2001 International Stock Incentive Plan. Such options will be subject to adjustment so that th |
|
| January 6, 2006 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-128899 PROSPECTUS U.S. CONVERSION OFFER Conversion Offer To U.S. holders of the non-voting preference shares without par value, including preference shares represented by American Depositary Shares, of Fresenius Medical Care AG We are offering holders of our non-voting preference shares, including preference shares represented |
|
| January 6, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| January 6, 2006 |
Form of Election To Convert American Depositary Shares (ADSs) representing Fresenius Medical Care AG Preference Shares The undersigned hereby submits to Fresenius Medical Care AG, the preference share ADSs plus €3. |
|
| January 4, 2006 |
Filed by Fresenius Medical Care Aktiengesellschaft, Commision File No. 001-14444, pursuant to Rules 165 and 425 under the Securities Act of 1933, as amended and Rule 13e-4(c) under the Securities Exchange Act of 1934, as amended. This filing consists of a press release issued by Fresenius Medical Care AG on January 4, 2006 in connection with its announcement of a proposed conversion of its outstan |
|
| January 4, 2006 |
LETTER TO THE S.E.C. Baker & McKenzie LLP 1114 Avenue of the Americas New York, New York 10036, USA Tel: +1 212 626 4100 Fax: +1 212 310 1600 www.bakernet.com Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest |
|
| January 4, 2006 |
As filed with the Securities and Exchange Commission on January 4, 2006 As filed with the Securities and Exchange Commission on January 4, 2006 Registration No. |
|
| January 3, 2006 |
Fresenius Medical Care AG Else-Kröner Strasse 1 61352 Bad Homburg Germany Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg Germany January 3, 2006 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| January 3, 2006 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2006 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark wh |
|
| December 30, 2005 |
Fresenius Medical Care AG Else-Kröner Strasse 1 61352 Bad Homburg Germany Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg Germany December 30, 2005 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| December 23, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| December 23, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care PRESS RELEASE Contact: Contact: Oliver Maier Heinz Schmidt Sr. V.P. Investor Relations & Communications Vice President Investor Relations Phone: + 49 6172 609 2601 Phone: 1- 781 402 4518 Fax: + 49 6172 609 2301 Fax: 1- 781 402 9741 E-mail: [email protected] E-mail: [email protected] - - Internet: http://www.fmc-ag.com - FRESENIUS MEDICAL CARE |
|
| December 23, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 23, 2005 |
(BAKER & MCKENZIE LOGO) BAKER & MCKENZIE LLP 1114 Avenue of the Americas New York, New York 10036, USA Tel: +1 212 626 4100 Fax: +1 212 310 1600 www. |
|
| December 23, 2005 |
As filed with the Securities and Exchange Commission on December 23, 2005 F-4/A 1 y13273a2fv4za.htm AMENDMENT NO. 2 TO FORM F-4 Table of Contents As filed with the Securities and Exchange Commission on December 23, 2005 Registration No. 333-128899 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to Form F-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Fresenius Medical Care Aktiengesellschaft (Exact Name of Registrant as Specified in |
|
| December 22, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 22, 2005 |
Exhibit 99.2 [GRAPHIC OMITTED] Fresenius Medical Care PRESS RELEASE Contact: Contact: Oliver Maier Heinz Schmidt Sr. V.P. Investor Relations & Communications Vice President Investor Relations Phone: + 49 6172 609 2601 Phone: 1- 781 402 4518 Fax: + 49 6172 609 2301 Fax: 1- 781 402 9741 E-mail: [email protected] E-mail: [email protected] - - Internet: http://www.fmc-ag.com - FRESENIUS MEDICAL CARE |
|
| December 22, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care PRESS RELEASE Contact: Contact: Oliver Maier Heinz Schmidt Sr. V.P. Investor Relations & Communications Vice President Investor Relations Phone: + 49 6172 609 2601 Phone: 1- 781 402 4518 Fax: + 49 6172 609 2301 Fax: 1- 781 402 9741 E-mail: [email protected] E-mail: [email protected] - - Internet: http://www.fmc-ag.com - FRESENIUS MEDICAL CARE |
|
| December 20, 2005 |
Filed by Fresenius Medical Care Aktiengesellschaft, Commision File No. 001-14444, pursuant to Rules 165 and 425 under the Securities Act of 1933, as amended and Rule 13e-4(c) under the Securities Exchange Act of 1934, as amended This filing consists of a press release issued by Fresenius Medical Care AG on December 20 2005 in connection with its announcement of a proposed conversion of its outstan |
|
| December 1, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care PRESS RELEASE Contact: Contact: Oliver Maier Heinz Schmidt Sr. V.P. Investor Relations & Communications Vice President Investor Relations Phone: + 49 6172 609 2601 Phone: 1- 781 402 4518 Fax: + 49 6172 609 2301 Fax: 1- 781 402 9741 E-mail: [email protected] E-mail: [email protected] - - Internet: http://www.fmc-ag.com - Fresenius Medical Care |
|
| December 1, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 29, 2005 |
6-K 1 fresen6k.txt FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2005 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive o |
|
| November 17, 2005 |
As filed with the Securities and Exchange Commission on November 17, 2005 Table of Contents As filed with the Securities and Exchange Commission on November 17, 2005 Registration No. |
|
| November 17, 2005 |
EX-99.1: FORM OF LETTER OF TRANSMITTAL Exhibit 99.1 Form of Election To Convert American Depositary Shares (ADSs) representing Fresenius Medical Care AG Preference Shares The undersigned hereby submits to Fresenius Medical Care AG, the preference share ADSs plus €3.25 per preference share ADSs (the “Conversion Premium”), as indicated in box 3. The undersigned hereby also tenders $ per preference ADS tendered for conversion (the “US Pre |
|
| November 17, 2005 |
EX-12.1: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EX-12.1 Exhibit 12.1 For the nine months ending September 30, For the years ended December 31, 2005 2004 2004 2003 2002 Earnings/Fixed Charge Ratio 4.64 3.96 4.03 3.16 2.62 Earnings Add: Pre-tax income 568,303 487,563 668,599 545,676 468,450 Fixed Charges 155,414 163,954 219,573 251,318 284,135 Total additions 723,717 651,517 888,172 796,994 752,585 Less: Interest Capitalized 1,020 1,088 1,611 920 |
|
| November 17, 2005 |
CORRESP Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest Cairo Düsseldorf Frankfurt / Main Geneva Kyiv London Madrid Milan Moscow Munich Paris Prague Riyadh Rome St. |
|
| November 17, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| November 17, 2005 |
Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany CORRESP2 Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany November 17, 2005 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| November 17, 2005 |
EX-99.2: FORM OF EXCHANGE AGENT AGREEMENT Exhibit 99.2 EXCHANGE AGENT AGREEMENT , 200 JPMorgan Chase Bank, N.A. 4 New York Plaza New York, New York 10004 Attention: Tenders & Exchanges Dear Sirs: Fresenius Medical Care AG, a stock corporation organized under the laws of the Federal Republic Germany (“Fresenius”), proposes to make an offer (the “Offer”) to convert preference share American depositary shares (“ADSs”) (each preference share |
|
| November 3, 2005 |
EX-10.1 2 f01084exv10w1.htm EXHIBIT 10.1 Exhibit 10.1 AMENDMENT NO. 4 Dated as of October 20, 2005 to THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT Dated as of October 23, 2003 THIS AMENDMENT NO. 4 (this “Amendment”) dated as of October 20, 2005 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the “Transferor”), (ii) NATIONAL MEDICAL CARE, INC., |
|
| November 3, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indica |
|
| November 3, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| November 3, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark w |
|
| November 3, 2005 |
Exhibit 10.2 AMENDMENT Dated as of October 20, 2005 to RECEIVABLES PURCHASE AGREEMENT Dated as of August 28, 1997 THIS AMENDMENT (this ?Amendment?) dated as of October 20, 2005 is entered into by and between NMC FUNDING CORPORATION, a Delaware corporation, as Purchaser (the ?Purchaser?) and NATIONAL MEDICAL CARE, INC., a Delaware corporation, as Seller (the ?Seller?). PRELIMINARY STATEMENTS A. The |
|
| October 18, 2005 |
Mail Stop 6010 October 17, 2005 Dr. Ben J. Lipps Fresenius Medical Care Holdings, Inc. 95 Hayden Avenue Lexington, MA 02420 Re: Fresenius Medical Care Corporation Registration Statement on Form F-4 Filed October 7, 2005 File No. 333-128899 Dear Dr. Lipps: This is to advise you that we are not conducting a full review of the above registration statement. However, we will be reviewing the Schedule T |
|
| October 11, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| October 11, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. ) Fresenius Medical Care AG (Name of Subject Company (issuer)) Fresenius Medical Care AG (issuer) Fresenius Medical Care AG & Co KGaA (issuer) (Names of Filing Persons (identifying status as offeror, issu |
|
| October 11, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of October 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark wh |
|
| October 7, 2005 |
EX-99.3: CONSENT OF GARY A. BRUKARDT PURSUANT TO RULE 438 Exhibit 99.3 Consent of Gary A. Brukardt Pursuant to Rule 438 I hereby consent to being named in the within registration statement as a person designated to be appointed to the management board of Fresenius Medical Care Management AG, the general partner of Fresenius Medical Care AG & Co. KGaA, and to the references to me in said registration statement. /s/ Gary A. Brukardt Gary A. Brukardt Nashvi |
|
| October 7, 2005 |
As filed with the Securities and Exchange Commission on October 7, 2005 Table of Contents As filed with the Securities and Exchange Commission on October 7, 2005 Registration No. |
|
| August 31, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2005 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check mark |
|
| August 31, 2005 |
Exhibit 99 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. |
|
| August 18, 2005 |
Exhibit 99 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. |
|
| August 18, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2005 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check mark |
|
| August 5, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whe |
|
| August 5, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| August 5, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| August 5, 2005 |
Exhibit 10.1 ARTICLES OF ASSOCIATION OF FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT I. General Terms ARTICLE 1 Firm Name and Registered Office The Company is a stock corporation. The name of the Company is Fresenius Medical Care Aktiengesellschaft The registered office of the Company is in Hof an der Saale. ARTICLE 2 Purpose (1) The purpose of the Company is a) the development, production and distri |
|
| July 26, 2005 |
EXHIBIT 99.1 Conversion Report on the Conversion of Preference Shares into Ordinary Shares THIS REPORT IS BEING DISTRIBUTED SOLELY IN FULFILLMENT OF THE LEGAL OBLIGATION OF THE MANAGMEMENT BOARD OF FRESENIUS MEDICAL CARE AG IN CONNECTION WITH THE PROPOSAL BEING SUBMITTED TO THE COMPANY'S SHAREHOLDERS TO AMEND THE COMPANY'S ARTICLES OF ASSOCIATION TO PROVIDE FOR THE CONVERSION OF THE COMPANY'S PREF |
|
| July 26, 2005 |
EXHIBIT 99.3 [GRAPHIC OMITTED] Fresenius Medical Care - - Fresenius Medical Care AG Transformation of the Legal Form into a Partnership Limited by Shares (KGaA) Report on Transformation by the Management Board - - 2 Important Notice: - This transformation report is neither an offer to sell voting bearer ordinary shares nor an invitation to make the Company an offer to buy voting bearer ordinary sh |
|
| July 26, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of July 2005 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check mark w |
|
| July 26, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of July 2005 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check mark w |
|
| July 26, 2005 |
Exhibit 99.1 Conversion Report on the Conversion of Preference Shares into Ordinary Shares THIS REPORT IS BEING DISTRIBUTED SOLELY IN FULFILLMENT OF THE LEGAL OBLIGATION OF THE MANAGMEMENT BOARD OF FRESENIUS MEDICAL CARE AG IN CONNECTION WITH THE PROPOSAL BEING SUBMITTED TO THE COMPANY'S PREFERENCE SHAREHOLDERS TO AMEND THE COMPANY'S ARTICLES OF ASSOCIATION TO PROVIDE FOR THE CONVERSION OF THE COM |
|
| July 26, 2005 |
EXHIBIT 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| July 26, 2005 |
EXHIBIT 99.2 Report on the Reasons for the Exclusion of the Pre-emptive Right in Connection with the Creation of Authorized Capital Appendix 2 to the Invitation to the Extraordinary General Meeting on 30 August 2005 Written Report of the Management Board to the extraordinary General Meeting as - - to the grounds for the exclusion of the pre-emption right (Sections 203 para. 2, - - second sentence, |
|
| July 26, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of July 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark wheth |
|
| July 20, 2005 |
Table of Contents Prospectus Filed Pursuant to Rule 424(b)3 Registration No. 333-124759 INVITATION TO THE EXTRAORDINARY GENERAL MEETING ISIN: DE 0005785802 // Securities Identification Numbers 578 580 ISIN: DE 0005785836 // Securities Identification Numbers 578 583 ISIN: DE 000A0DRW61 // Securities Identification Numbers A0DRW6 ISIN: US 3580291066 // American Depositary Receipts Numbers 879 529 IS |
|
| July 19, 2005 |
As filed with the Securities and Exchange Commission on July 19, 2005 Table of Contents As filed with the Securities and Exchange Commission on July 19, 2005 Registration No. |
|
| July 19, 2005 |
Via Facsimile and U.S. Mail Mail Stop 03-09 May 26, 2005 Dr. Ben J. Lipps Chief Executive Officer 95 Hayden Avenue Lexington, MA 02420 Re: Fresenius Medical Care Corporation Form 20-F for the fiscal year ended December 31, 2004 File No. 1-14444 Dear Dr. Lipps: We have reviewed your filing and have the following comments. We have limited our review of the above referenced filing to only those issue |
|
| July 19, 2005 |
corresp1 Baker & McKenzie LLP 805 Third Avenue New York, NY 10022, USA Tel: +1 212 751 5700 Fax: +1 212 759 9133 www. |
|
| July 19, 2005 |
Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany corresp2 Fresenius Medical Care AG Else-Kröner-Strasse 1 61352 Bad Homburg Germany July 19, 2005 Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| July 13, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A Amendment No. 1 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A Amendment No. 1 o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2004 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 |
|
| July 13, 2005 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the amended Annual Report on Form 20-F/A of Fresenius Medical Care AG (the ?Company?) for the year ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned, Dr. Ben Lipps, Chief |
|
| July 13, 2005 |
exv12w2 Exhibit 12.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lawrence Rosen, certify that: 1. I have reviewed this amended annual report on Form 20-F/A of Fresenius Medical Care Aktiengesellschaft (the “Report”). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st |
|
| July 13, 2005 |
Exhibit 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ben J. Lipps, certify that: 1. I have reviewed this amended annual report on Form 20-F/A of Fresenius Medical Care Aktiengesellschaft (the ?Report?). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements m |
|
| July 11, 2005 |
Board of Management VIA EDGAR AND FAX (202) 772-9217 Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, D.C. 20549 July 6, 2005 Re: Fresenius Medical Care Corporation Form 20-F for fiscal year ended December 31, 2004 File No. 1-14444 Dear Mr. Rosenberg, On behalf of Fresenius Medical Care AG (the |
|
| July 5, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com July |
|
| July 5, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 1, 2005 |
EX-99.1: VOTING INSTRUCTION CARD Exhibit 99.1 TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS (?ADRs?) REPRESENTING ORDINARY BEARER SHARES OF FRESENIUS MEDICAL CARE AG (THE ?COMPANY?) CUSIP NUMBER 358029106 JPMorgan Chase Bank, N.A., Depositary (the ?Depositary?) has received advice that the Extraordinary General Meeting (the ?Meeting?) of Shareholders will be held at Germany, on , 2005, beginning at 10:00 a.m., for the |
|
| July 1, 2005 |
EX-4.3: FORM OF POOLING AGREEMENT Exhibit 4.3 FRESENIUS AKTIENGESELLSCHAFT ELSE-KR?NER STRASSE 1 61352 BAD HOMBURG v.d.H GERMANY , 2005 Mr. Walter L. Weisman Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg v.d.H. Germany Mr. John G. Kringel Fresenius Medical Care AG Else-Kr?ner Strasse 1 61352 Bad Homburg v.d.H. Germany Gentlemen: We refer to (i) the Pooling Agreement dated as of September 27, 1996 (the ?Ordinary |
|
| July 1, 2005 |
As filed with the Securities and Exchange Commission on July 1, 2005 Table of Contents As filed with the Securities and Exchange Commission on July 1, 2005 Registration No. |
|
| July 1, 2005 |
EX-99.1: VOTING INSTRUCTION CARD Exhibit 99.2 TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS (?ADRs?) REPRESENTING PREFERENCE SHARES OF FRESENIUS MEDICAL CARE AG (THE ?COMPANY?) CUSIP NUMBER 358029205 JPMorgan Chase Bank, N.A., Depositary (the ?Depositary?) has received advice that the Separate Meeting of Preference Shareholders (the ?Meeting?) will be held at the Germany, on , 2005, beginning at 10:00 a.m., for the pu |
|
| July 1, 2005 |
RE: Fresenius Medical Care AG Registration Statement on Form F-4 File No. 333-124759 CORRESP Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest Cairo Düsseldorf Frankfurt / Main Geneva Kyiv London Madrid Milan Moscow July 1, 2005 VIA EDGAR AND FED EX Jeffrey P. |
|
| June 16, 2005 |
Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Bologna Brussels Budapest Cairo D?sseldorf Frankfurt / Main Geneva Kyiv London Madrid Milan Moscow Munich Paris Prague Riyadh Rome St. |
|
| June 16, 2005 |
Board of Management VIA EDGAR AND FAX (202) 772-9217 Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, D.C. 20549 June 16, 2005 Re: Fresenius Medical Care Corporation Form 20-F for fiscal year ended December 31, 2004 File No. 1-14444 Dear Mr. Rosenberg, On behalf of Fresenius Medical Care AG (the |
|
| June 15, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com June |
|
| June 15, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 7, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| June 7, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 31, 2005 |
Mail Stop 6010 May 31, 2005 Dr. Ben J. Lipps Fresenius Medical Care Holdings, Inc. 95 Hayden Avenue Lexington, MA 02420 Re: Fresenius Medical Care Corporation Registration Statement on Form F-4 File Number 333-124759 Dear Dr. Lipps: This is to advise you that we have limited our review of the above referenced registration statements to only the issues identified below. Where indicated, we think yo |
|
| May 20, 2005 |
As filed with the Securities and Exchange Commission on May 20, 2005 Table of Contents As filed with the Securities and Exchange Commission on May 20, 2005 Registration No. |
|
| May 20, 2005 |
COVER Baker & McKenzie LLP 805 Third Avenue New York, NY 10022, USA Tel: +1 212 751 5700 Fax: +1 212 759 9133 www. |
|
| May 10, 2005 |
As filed with the Securities and Exchange Commission on May 10, 2005 Table of Contents As filed with the Securities and Exchange Commission on May 10, 2005 Registration No. |
|
| May 5, 2005 |
Exhibit 10.3 AGREEMENT Dated as of May 3, 2005, Among FRESENIUS MEDICAL CARE AG, FRESENIUS MEDICAL CARE HOLDINGS, INC. FLORENCE ACQUISITION, INC. And RENAL CARE GROUP, INC. TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 1 SECTION 1.02. Closing 1 SECTION 1.03. Effective Time 1 SECTION 1.04. Effects 1 SECTION 1.05. Certificate of Incorporation and By-laws 1 SECTION 1.06. Direct |
|
| May 5, 2005 |
Exhibit 10.2 AMENDMENT NO. 3 Dated as of January 1, 2005 to THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT Dated as of October 23, 2003 THIS AMENDMENT NO. 3 (this ?Amendment?) dated as of January 1, 2005 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the ?Transferor?), (ii) NATIONAL MEDICAL CARE, INC., a Delaware corporation, as collection agent |
|
| May 5, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| May 5, 2005 |
Exhibit 10.1 SECOND AMENDMENT TO SUBORDINATED LOAN NOTE By this Allonge (this ?Allonge?), to the Subordinated Loan Note dated as of May 18, 1999 by the undersigned Borrowers in favor of Fresenius AG, a German corporation, in the maximum principal amount of $400,000,000 (as amended by an Allonge dated as of September 29, 2003, the ?Note?) the Borrowers and the Lender hereby agree as follows: 1. All |
|
| May 4, 2005 |
Fresenius Medical Care Reports First Quarter 2005 Results; Solid Start into the Year 2005 Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 04, 2005 Fresenius Medical Care Reports F |
|
| May 4, 2005 |
WHERE YOU CAN FIND MORE INFORMATION Filed by Fresenius Medical Care Aktiengesellschaft pursuant to Rules 165 and 425 promulgated under the Securities Act of 1933, as amended This filing consists of an investor presentation and press release issued by Fresenius Medical Care AG on May 4, 2005 in connection with its announcement of a proposed conversion of its outstanding preference shares into ordinary shares and transformation of the legal form of Fresenius Medical Care AG. |
|
| May 4, 2005 |
FRESENIUS MEDICAL CARE CORP. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) |
|
| May 4, 2005 |
Fresenius Medical Care to Acquire Renal Care Group, Inc. Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 04, 2005 Fresenius Medical Care to Acquir |
|
| May 4, 2005 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| April 21, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| April 21, 2005 |
Exhibit 99.1 - - [GRAPHIC OMITTED] Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com April 21, 2005 FRESENIU |
|
| April 15, 2005 |
[GRAPHIC OMITTED] Fresenius Medical Care Exhibit 99.6 - SUPPLEMENTAL INFORMATION As a foreign corporation, Fresenius Medical Care is not presently subject to the SEC's Proxy Rules. However, under the stipulations of certain Pooling Agreements Fresenius Medical Care has agreed to provide information to shareholders which was roughly comparable to that which would be provided by a U.S. corporation, |
|
| April 15, 2005 |
Exhibit 99.2 TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS ("ADRs") REPRESENTING ORDINARY BEARER SHARES OF FRESENIUS MEDICAL CARE AG (THE "COMPANY") CUSIP NUMBER 358029106 JPMorgan Chase Bank, N.A., Depositary (the "Depositary") has received advice that the Ordinary General Meeting (the "Meeting") of Shareholders will be held at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage |
|
| April 15, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| April 15, 2005 |
Exhibit 99.3 1 - - Agenda of the Special Meeting of Preference Shareholders FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT Hof an der Saale Invitation to the Special Meeting of Preference Shareholders - - ISIN: DE 0005785836 // Securities Identification Number 578 583 - - - ISIN: DE 000A0DRW61 // Securities Identification Number A0DRW6 - - - ISIN: US 3580292056 // American Depository Receipts Identific |
|
| April 15, 2005 |
TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS ("ADRs") REPRESENTING PREFERENCE SHARES OF FRESENIUS MEDICAL CARE AG (THE "COMPANY") CUSIP NUMBER 358029205 JPMorgan Chase Bank, N. |
|
| April 15, 2005 |
Exhibit 99.1 1 - - Agenda of the General Meeting FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT Hof an der Saale Invitation to the Ordinary General Meeting - - ISIN: DE 0005785802 // Securities Identification Number 578 580 - - - ISIN: DE 0005785836 // Securities Identification Number 578 583 - - - ISIN: DE 000A0DRW61 // Securities Identification Number A0DRW6 - - - ISIN: US 3580291066 // American Depo |
|
| April 15, 2005 |
Report of the Supervisory Board - of Fresenius Medical Care Aktiengesellschaft - for the Fiscal Year 2004 - In the fiscal year 2004, the Managing Board again informed the Supervisory Board comprehensively, regularly and promptly about the progress of the business activities, the situation of the company and important business transactions. |
|
| April 12, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| April 12, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| April 6, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 6, 2005 | ||
| April 6, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2005 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check mark |
|
| April 6, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| March 1, 2005 |
EXHIBIT 12.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lawrence Rosen, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in |
|
| March 1, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2004 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT |
|
| March 1, 2005 |
EXHIBIT 2.28 SUPPLEMENTAL INDENTURE THIS SUPPLEMENTAL INDENTURE is dated as of December 23, 2004, by and among FRESENIUS MEDICAL CARE AG (the "Company"), a German stock corporation (Aktiengesellschaft), U.S. BANK NATIONAL ASSOCIATION, a national banking association, as successor trustee to STATE STREET BANK AND TRUST COMPANY, a Massachusetts chartered trust company, as trustee (the "Trustee"), FMC |
|
| March 1, 2005 |
EXHIBIT 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ben J. Lipps, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in li |
|
| March 1, 2005 |
EXHIBIT 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Fresenius Medical Care AG (the "Company") for the year ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Dr. Ben Lipps, Chief Executive |
|
| March 1, 2005 |
EXHIBIT 2.27 SUPPLEMENTAL INDENTURE THIS SUPPLEMENTAL INDENTURE is dated as of December 23, 2004, by and among FRESENIUS MEDICAL CARE AG (the "Company"), a German stock corporation (Aktiengesellschaft), U.S. BANK NATIONAL ASSOCIATION, a national banking association, as successor trustee to STATE STREET BANK AND TRUST COMPANY, a Massachusetts chartered trust company, as trustee (the "Trustee"), FMC |
|
| March 1, 2005 |
EXHIBIT 4.19 (AMGEN LOGO) AMENDED AND RESTATED FREESTANDING DIALYSIS CENTER AGREEMENT NO. 200308358 - - The undersigned hereby agree to amend and restate Freestanding Dialysis Center Agreement No. 200308358 (the "Agreement"), between Amgen USA Inc. ("Amgen"), a wholly-owned subsidiary of Amgen Inc., and National Medical Care, Inc., including all subsidiaries and affiliates that are at least fifty |
|
| March 1, 2005 |
EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Supervisory Board and Shareholders of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany: We consent to the incorporation by reference in the Registration Statement on Form S-8 of Fresenius Medical Care Aktiengesellschaft of our report dated February 11, 2004 with respect to the consolidated balance sheet |
|
| March 1, 2005 |
EXHIBIT 2.37 AMENDMENT NO. 3 dated as of December 10, 2004 to AMENDED AND RESTATED CREDIT AGREEMENT dated as of February 21, 2003 among FRESENIUS MEDICAL CARE HOLDINGS, INC., a New York corporation, FRESENIUS MEDICAL CARE AG, a German corporation, and the other Borrowers and Guarantors identified therein, the Lenders identified therein, and BANK OF AMERICA, N.A., as Administrative Agent BANC OF AM |
|
| February 24, 2005 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| February 24, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark w |
|
| February 14, 2005 |
SCHEDULE 13G Amendment No. 1 Fresenius Medical Care AG Common Stock Cusip # D2734Z107 Cusip # D2734Z107 Item 1: Reporting Person - FMR Corp. Item 4: Delaware Item 5: 646,387 Item 6: 0 Item 7: 1,662,305 Item 8: 0 Item 9: 1,662,305 Item 11: 2.375% Item 12: HC Cusip # D2734Z107 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 1,662,305 Item |
|
| January 25, 2005 |
EXHIBIT 99.1 Fresenius Medical Care AG [GRAPHIC OMITTED] Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com - |
|
| January 25, 2005 |
KAWASUMI LABORATORIES, INC. FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2005 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark wh |
|
| January 14, 2005 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 16, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark w |
|
| December 16, 2004 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| November 12, 2004 |
Table of Contents Exhibit 10.1 AMENDMENT NO. 2 Dated as of October 21, 2004 to THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT Dated as of October 23, 2003 THIS AMENDMENT NO. 2 (this ?Amendment?) dated as of October 21, 2004 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the ?Transferor?), (ii) NATIONAL MEDICAL CARE, INC., a Delaware corporation, |
|
| November 12, 2004 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indica |
|
| November 3, 2004 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| November 3, 2004 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 27, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of October 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark wh |
|
| October 27, 2004 |
Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com October 27, 2004 Bad Homburg, Germany ? Octob |
|
| September 30, 2004 |
Back to Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of September 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indi |
|
| September 30, 2004 |
Exhibit 10.1 AMENDMENT TO SUBORDINATED LOAN NOTE By this Allonge (this "ALLONGE"), to the Subordinated Loan Note dated as of May 18, 1999 by the undersigned Borrowers in favor of Fresenius AG, a German corporation, in the maximum principal amount of $400,000,000 (the "NOTE") the Borrowers and the Lender hereby agree as follows: 1. All capitalized terms used herein without definition shall have the |
|
| August 11, 2004 |
Exhibit 10.1 AMENDMENT TO SUBORDINATED LOAN NOTE By this Allonge (this "ALLONGE"), to the Subordinated Loan Note dated as of May 18, 1999 by the undersigned Borrowers in favor of Fresenius AG, a German corporation, in the maximum principal amount of $400,000,000 (the "NOTE") the Borrowers and the Lender hereby agree as follows: 1. All capitalized terms used herein without definition shall have the |
|
| August 11, 2004 |
Back to Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| August 4, 2004 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| August 4, 2004 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 12, 2004 |
Exhibit 2.30 AMENDMENT NO. 1 DATED AS OF MARCH 31, 2004 TO THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT DATED AS OF OCTOBER 23, 2003 THIS AMENDMENT NO. 1 (this "Amendment") dated as of March 31, 2004 is entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the "Transferor"), (ii) NATIONAL MEDICAL CARE, INC., a Delaware corporation, as collection agent ( |
|
| May 12, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whethe |
|
| May 12, 2004 |
Exhibit 10.1 Published CUSIP Number: 35803CAA6 AMENDMENT NO. 2 DATED AS OF MAY 7, 2004 TO AMENDED AND RESTATED CREDIT AGREEMENT DATED AS OF FEBRUARY 21, 2003 AMONG FRESENIUS MEDICAL CARE HOLDINGS, INC., A NEW YORK CORPORATION, FRESENIUS MEDICAL CARE AG, A GERMAN CORPORATION, AND THE OTHER BORROWERS AND GUARANTORS IDENTIFIED THEREIN, THE LENDERS IDENTIFIED THEREIN, AND BANK OF AMERICA, N.A., AS ADM |
|
| May 6, 2004 |
Fresenius Medical Care reports First Quarter 2004 results; First quarter ahead of expectations Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 6, 2004 Fresenius Medical Care reports Fi |
|
| May 6, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whethe |
|
| April 14, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| April 14, 2004 |
TO THE REGISTERED HOLDERS OF AMERICAN DEPOSITARY RECEIPTS ("ADRs") REPRESENTING ORDINARY BEARER SHARES OF FRESENIUS MEDICAL CARE AG (THE ?COMPANY?) CUSIP NUMBER 358029106 JPMorgan Chase Bank, Depositary (the ?Depositary?) has received advice that the Ordinary General Meeting (the ?Meeting?) of Shareholders will be held at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany, on Thursday, May 27, 2004, beginning at 10:00 a. |
|
| April 14, 2004 |
Exhibit 99.1 Agenda of the General Meeting FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT Hof an der Saale Invitation to the Ordinary General Meeting ? ISIN: DE 0005785802 // Securities Identification Numbers 578 580 ? ? ISIN: DE 0005785836 // Securities Identification Numbers 578 583 ? ? ISIN: DE 000A0AHS96 // Securities Identification Numbers A0AHS9 ? ? ISIN: US 3580291066 // American Depositary Rece |
|
| April 14, 2004 |
Supplemental Information As a foreign corporation, Fresenius Medical Care is not presently subject to the SEC?s Proxy Rules. |
|
| April 14, 2004 |
Exhibit 99.3 Report of the Supervisory Board of Fresenius Medical Care Aktiengesellschaft for the Financial Year 2003 The Managing Board informed the Supervisory Board comprehensively, regularly and in good time about the progress of the business activities, the situation of the company and important business transactions. Additionally, the chairman of the Supervisory Board was informed by the Man |
|
| March 5, 2004 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2004 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| March 2, 2004 |
EXHIBIT 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Fresenius Medical Care AG (the "Company") for the year ended December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Dr. Ben Lipps, Chief Executive |
|
| March 2, 2004 |
EXHIBIT 4.19 AMGEN FREESTANDING DIALYSIS CENTER AGREEMENT This Agreement ("Agreement"), between Amgen USA Inc. ("Amgen"), a wholly-owned subsidiary of Amgen Inc., and National Medical Care, Inc., including all subsidiaries and affiliates that are at least fifty and one-tenth percent (50.10%) owned by National Medical Care, Inc. and listed on Appendix B, (collectively, "NMC"), sets forth the terms |
|
| March 2, 2004 |
EXHIBIT 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ben J. Lipps, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in li |
|
| March 2, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT |
|
| March 2, 2004 |
EXHIBIT 2.29 - - THIRD AMENDED AND RESTATED TRANSFER AND ADMINISTRATION AGREEMENT among PARADIGM FUNDING LLC, GIRO MULTI-FUNDING CORPORATION, ASSET ONE SECURITIZATION, LLC LIBERTY STREET FUNDING CORP. as Conduit Investors NMC FUNDING CORPORATION, as Transferor NATIONAL MEDICAL CARE, INC., as Collection Agent THE FINANCIAL INSTITUTIONS PARTIES HERETO, as Bank Investors BAYERISCHE LANDESBANK, NEW YO |
|
| March 2, 2004 |
EXHIBIT 12.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lawrence Rosen, certify that: 1. I have reviewed this annual report on Form 20-F of Fresenius Medical Care Aktiengesellschaft (the "Report"). 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in |
|
| March 2, 2004 |
EXHIBIT 14.1 CONSENT OF INDEPENDENT AUDITORS To the Supervisory Board and Shareholders of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany We consent to the incorporation by reference in the Registration Statement on Form S-8 of Fresenius Medical Care Aktiengesellschaft of our report dated February 10, 2004 relating to the consolidated balance sheets of Fresenius Medical Care Ak |
|
| March 2, 2004 |
EXHIBIT 11.1 FRESENIUS MEDICAL CARE CODE OF BUSINESS CONDUCT December 2003 . . . TABLE OF CONTENTS PAGE - Foreword.................................................... 1 Setting the Standard........................................ 2 Mission Statement and Core Values........................... 3 Fresenius Corporate Compliance Program...................... 4 Who is Covered............................ |
|
| February 25, 2004 |
[GRAPHIC OMITTED] Fresnius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. |
|
| February 25, 2004 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 17, 2004 |
SCHEDULE 13G Amendment No. 0 Fresenius Medical Care AG Common Stock Cusip # D2734Z107 Cusip # D2734Z107 Item 1: Reporting Person - FMR Corp. Item 4: Delaware Item 5: 1,151,423 Item 6: 0 Item 7: 3,649,110 Item 8: 0 Item 9: 3,649,110 Item 11: 5.213% Item 12: HC Cusip # D2734Z107 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 3,649,110 Ite |
|
| November 14, 2003 |
6-K 1 f00647e6vk.htm FORM 6-K Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of princ |
|
| November 5, 2003 |
[COMPANY LOGO GRAPHIC OMITTED] Fresenius Medical Care AG Investor News Investor Relations Else-Kroner-Str. |
|
| November 5, 2003 |
- - - - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2003 - FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| September 9, 2003 |
================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 4, 2003 |
Fresenius Medical Care announces appointment of new Chief Financial Officer Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com September 4, 2003 Fresenius Medical Care anno |
|
| September 4, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of September 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indic |
|
| August 18, 2003 |
================================================================================ SECURITIES AND EXCHANGE COMMISION Washington D. |
|
| August 14, 2003 |
Exhibit 1.1 ARTICLES OF ASSOCIATION OF FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT I. General Terms Article 1 Firm Name and Registered Office The Company is a stock corporation. The name of the Company is Fresenius Medical Care Aktiengesellschaft The registered office of the Company is in Hof an der Saale. Article 2 Purpose (1) The purpose of the Company is a) the development, production and distrib |
|
| August 14, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| August 5, 2003 |
Fresenius Medical Care AG reports Second Quarter and Six Months Results 2003 EX-99.1 3 f00604exv99w1.htm EXHIBIT 99.1 Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kröner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com Augu |
|
| August 5, 2003 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whe |
|
| May 16, 2003 |
Exhibit 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of May, 2003 containing its unaudited financial statements as of and for three month period ending March 31, 2002 as submitted to the Securities and Exchange |
|
| May 16, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| May 16, 2003 |
Exhibit 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of May, 2003 containing its unaudited financial statements as of and for three month period ending March 31, 2003 as submitted to the Securities and Exchange |
|
| May 7, 2003 |
Fresenius Medical Care reports First Quarter 2003 results Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kr?ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com May 7, 2003 Fresenius Medical Care reports Fi |
|
| May 7, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by |
|
| April 22, 2003 |
SECURITIES AND EXCHANGE COMMISION Washington D.C. 20549 - FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month April 2003 - Fresenius Medical Care Corporation - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg v.d.H. Germany - (Address of principal executive offices) Indicate by check |
|
| April 22, 2003 |
Exhibit 99.3 Report of the Supervisory Board - of Fresenius Medical Care Aktiengesellschaft - for the 2002 Financial Year - The Managing Board informed the Supervisory Board comprehensively, regularly and in good time about the progress of the business activities, the situation of the company and important business transactions. On the basis of written and oral reports of the Managing Board, the S |
|
| April 22, 2003 |
Exhibit 99.2 [X] PLEASE MARK VOTES AS IN THIS EXAMPLE - - FRESENIUS MEDICAL CARE AG - - For Against For Against ORDINARY BEARER SHARES Resolution 1 **non-voting* Resolution 4 [ ] [ ] * - - PLEASE REFER TO THE REVERSE OF THIS CARD FOR THE RESOLUTIONS TO BE VOTED AT THE MEETING. Resolution 2 [ ] [ ] Resolution 5 [ ] [ ] - - CONTROL NUMBER: Resolution 3 [ ] [ ] Resolution 6 [ ] [ ] Mark box at right |
|
| April 22, 2003 |
Exhibit 99.4 [GRAPHIC OMITTED] Fresenius Medical Care Supplemental Information As a foreign corporation, Fresenius Medical Care is not presently subject to the SEC's Proxy Rules. However, under the stipulations of certain Pooling Agreements Fresenius Medical Care has agreed to provide information to shareholders which was roughly comparable to that which would be provided by a U.S. corporation, ex |
|
| April 14, 2003 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| April 14, 2003 |
[Fresenius Medical Care Logo] INVESTOR NEWS FRESENIUS MEDICAL CARE AG INVESTOR RELATIONS Else-Kroner-Str. |
|
| April 8, 2003 |
SECURITIES AND EXCHANGE COMMISION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month April 2003 Fresenius Medical Care Corporation (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg v.d.H. Germany (Address of principal executive offices) Indicate by check mark wh |
|
| March 18, 2003 |
EX-10.1 3 f00517exv10w1.txt CONSENT OF KPMG EXHIBIT 10.1 CONSENT OF INDEPENDENT AUDITORS To the Supervisory Board and Shareholders of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany We consent to the incorporation by reference in the Registration Statement on Form S-8 of Fresenius Medical Care Aktiengesellschaft of our report dated February 21, 2003 relating to the consolidated |
|
| March 18, 2003 |
EX-10.3 5 f00517exv10w3.txt CERTIFICATION LIPPS EXHIBIT 10.3 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Fresenius Medical Care AG (the "Company") on Form 20F filed during the month of March 2003 as submitted to the Securities and Exchange Commission on the date hereof (the "Report"), |
|
| March 18, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2002 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT |
|
| March 18, 2003 |
EX-10.4 6 f00517exv10w4.txt CERTIFICATION SCHEIDER EXHIBIT 10.4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Fresenius Medical Care AG (the "Company") on Form 20-F filed during the month of March, 2003 as submitted to the Securities and Exchange Commission on the date hereof (the "Repo |
|
| March 18, 2003 |
Pages from Prospectus dated 20 July 2000 EXHIBIT 10.2 EXCERPT FROM PROSPECTUS DATED JULY 20, 2000 OF FRESENIUS MEDICAL CARE AG DESCRIPTION OF THE POOLING AGREEMENTS The following is a summary of the material provisions of the Ordinary shares pooling agreement, dated as of September 27, 1996 among Fresenius AG, our independent directors as agents of the minority holders of Ordinary shares, and us, and the Preference shares pooling agreeme |
|
| March 7, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| February 25, 2003 |
Fresenius Medical Care reports Fourth Quarter and Full-Year 2002 results Exhibit 99.1 Investor News Fresenius Medical Care AG Investor Relations Else-Kröner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com February 25, 2003 Fresenius Medical Care repo |
|
| February 25, 2003 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant?s name into English) Else-Kr?ner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indica |
|
| February 12, 2003 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2002 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check ma |
|
| February 12, 2003 |
EX-99.1 3 ex991.txt EXHIBIT 99.1 Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Int |
|
| February 4, 2003 |
Exhibit 99.1 FRESENIUS MEDICAL CARE AG INVESTOR NEWS INVESTOR RELATIONS Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com - FRESENIUS MEDICAL CARE ANNOUNCES EXERCISE O |
|
| February 4, 2003 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2003 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark w |
|
| December 2, 2002 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December 2002 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check ma |
|
| December 2, 2002 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| November 15, 2002 |
Exhibit 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of November, 2002 containing its unaudited financial statements as of and for three and nine month periods ending September 30, 2002 as submitted to the Secur |
|
| November 15, 2002 |
Exhibit 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of November, 2002 containing its unaudited financial statements as of and for three and nine month periods ending September 30, 2002 as submitted to the Secur |
|
| November 15, 2002 |
e6vk Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2002 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) I |
|
| October 29, 2002 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of October 2002 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check mar |
|
| October 29, 2002 |
Exhibit 99.1 [GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier - Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt - Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: http://www.fmc-ag.com |
|
| August 15, 2002 |
Exhibit 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of August, 2002 containing its unaudited financial statements as of and for three and six month periods ending June 30, 2002 as submitted to the Securities an |
|
| August 15, 2002 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2002 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant’s name into English) Else-Kröner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate |
|
| August 15, 2002 |
Exhibit 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Report of Fresenius Medical Care AG (the ?Company?) on Form 6-K filed during the month of August, 2002 containing its unaudited financial statements as of and for three and six month periods ending June 30, 2002 as submitted to the Securities an |
|
| July 30, 2002 |
[GRAPHIC OMITTED] Fresenius Medical Care Investor News Fresenius Medical Care AG Investor Relations Else-Kroner-Str. |
|
| July 30, 2002 |
6-K 1 fres6k.txt FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of July 2002 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices |
|
| May 23, 2002 |
- - - - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2002 - FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) ELSE-KRONER STRASSE 1 61346 BAD HOMBURG GERMANY (Address of principal executive offices) Indicate by check |
|
| May 1, 2002 |
FRESENIUS MEDICAL CARE Fresenius Medical Care AG Investor News Investor Relations Else-Kroner-Str. |
|
| May 1, 2002 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2002 FRESENIUS MEDICAL CARE CORPORATION - (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany - (Address of principal executive offices) Indicate by check mark wh |
|
| April 30, 2002 |
Exhibit 99.1 Agenda of the General Meeting FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT Hof an der Saale Invitation to the Ordinary General Meeting - - Securities Identification Number 578 580 / 578 581 / 578 583 / 578 584 - - - American Depositary Receipts Identification Number 879 529 / 903 780 - We hereby invite our shareholders to the Ordinary General Meeting to be held at the Marriott Hotel Fran |
|
| April 30, 2002 |
SECURITIES AND EXCHANGE COMMISION Washington D.C. 20549 - FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month April 2002 - Fresenius Medical Care Corporation (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg v.d.H. Germany (Address of principal executive offices) Indicate by check mar |
|
| April 9, 2002 |
- - - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - FORM 20-F/A AMENDMENT NO. 1 [ ] REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2001 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d |
|
| April 9, 2002 |
EXHIBIT 10.1 INDEPENDENT AUDITORS' CONSENT The Board of Directors and Shareholders of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany: We consent to the incorporation by reference in the registration statement on Form S-8 of Fresenius Medical Care Aktiengesellschaft relating to relating to the Fresenius Medical Care AG 1998 Stock Incentive Plan (the "Form S-8") of our report da |
|
| April 3, 2002 |
FORM 20-F FRESENIUS MEDICAL CARE 20-F 1 f00356e20-f.txt FORM 20-F FRESENIUS MEDICAL CARE - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - FORM 20-F [ ] REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2001 OR [ ] TRANSITION REP |
|
| March 27, 2002 |
6-K 1 fres6k.txt FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2002 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) I |
|
| March 27, 2002 |
EX-99.2 4 ex992.txt EXHIBIT 99.2 FRESENIUS MEDICAL CARE AG CHIEF FINANCIAL OFFICER'S CERTIFICATE The undersigned, Ulf M. Schneider, HEREBY CERTIFIES that: 1. I am a member of the Board of Management and the Chief Financial Officer of Fresenius Medical Care AG (the "Company"). This Certificate is delivered pursuant to Section 2(b)(v) of the Certificate of Amendment of the Certificate of Incorporati |
|
| March 27, 2002 |
EX-99.3 5 ex993.txt EXHIBIT 99.3 To the Board of Management of Fresenius Medical Care Aktiengesellschaft Hof an der Saale, Germany We have reviewed the accompanying schedule of special dividend calculation of Fresenius Medical Care AG for the five-year period from January 1, 1997 to December 31, 2001. Fresenius Medical Care AG's management is responsible for the schedule of special dividend calcul |
|
| March 27, 2002 |
EX-99.1 3 ex991.txt EXHIBIT 99.1 [GRAPHIC LOGO OMITTED] Fresenius Medical Care Fresenius Medical Care AG Investor News InvestorRelations Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet: ht |
|
| March 5, 2002 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2002 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark whet |
|
| March 5, 2002 |
EX-99.1 3 fresen991.txt EXHIBIT 99.1 [GRAPHIC LOGO OMITTED] Fresenius Medical Care INVESTOR NEWS FRESENIUS MEDICAL CARE AG INVESTORRELATIONS Else-Kroner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: [email protected] North America: Heinz Schmidt Phone: + 1 781 402 9000 Ext.: 4518 Fax: + 1 781 402 9741 E-mail: [email protected] Internet |
|
| February 14, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1) Fresenius Medical Care AG - (Name of issuer) Ordinary Shares - (Title of class of securities) 3580291066 - (CUSIP number) December 31, 2001 - (Date of Event which requires filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| February 13, 2002 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2002 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark w |
|
| November 26, 2001 |
- - - - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2001 - FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) ELSE-KRONER STRASSE 1 61346 BAD HOMBURG GERMANY (Address of principal executive offices) Indicate by |
|
| November 1, 2001 |
[GRAPHIC OMITTED] Fresenius Medical Care Fresenius Medical Care AG Investor News Investor Relations Else-Kroner-Str. |
|
| November 1, 2001 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2001 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark w |
|
| October 18, 2001 |
FRESENIUS MEDICAL CARE P R E S S R E L E A S E October 17, 2001 Oliver Heieck, Corporate Communications Tel. |
|
| October 18, 2001 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of October 2001 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark wh |
|
| October 5, 2001 |
1 Filed Pursuant to Rule 424(b)(3) Registration Nos. 333-66558, 333-66558-01, 333-66558-02, 333-66558-03, 333-66558-04 and 333-66558-05 SUPPLEMENT DATED OCTOBER 4, 2001 TO PROSPECTUS DATED AUGUST 29, 2001 EXTENSION OF EXCHANGE OFFERS - Fresenius Medical Care Capital Trust IV and Fresenius Medical Care Capital Trust V have extended the Expiration Dates of their respective Exchange Offers made by th |
|
| August 29, 2001 |
1 Filed Purusuant to Rule 424(b)(3) Registration Nos. 333-66558, 333-66558-01, 333-66558-02, 333-66558-03, 333-66558-04 and 333-66558-05 [FRESENIUS MEDICAL CARE LOGO] PROSPECTUS FRESENIUS MEDICAL CARE CAPITAL TRUST IV Offer to Exchange any and all of its outstanding 7 7/8% Trust Preferred Securities (Liquidation Amount $1,000 per Trust Preferred Security), for 7 7/8% Trust Preferred Securities (Li |
|
| August 27, 2001 |
1 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 27, 2001 REGISTRATION NO. |
|
| August 27, 2001 |
1 Exhibit 12.2 FRESENIUS MEDICAL CARE HOLDINGS, INC. Ratio of Fixed Charges to Earnings calculation $ Millions SIX MONTHS Nine Months Ended June 30, Year Ended December 31, Ended Sept 30 - - - 2001 2000 2000 1999 1998 1997 1996 (a) 1996(b) - - - - - - - - Fixed Charges Interest Expense including amortization of financing fees 102 110 217 202 209 178 43 16 add: one third of rental expense under ope |
|
| August 27, 2001 |
1 Exhibit 12.1 Fresenius Medical Care AG (US dollars in thousands) Ratio of combined fixed charges and Preference share dividends to earnings 6 Months 6 Months December 31, 6/30/01 6/30/00 2000 1999 1998 1997 1996 - - - - - - - Earnings EBT 213,419 188,391 404,708 (258,910) 269,437 207,388 144,702 Fixed Charges 122,213 123,653 238,843 236,626 236,795 200,895 64,750 Adjustments (876) (876) (1,752) |
|
| August 22, 2001 |
FRESENIUS MEDICAL CARE CORPORATION 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2001 FRESENIUS MEDICAL CARE CORPORATION (Translation of registrant's name into English) Else-Kroner Strasse 1 61346 Bad Homburg Germany (Address of principal executive offices) Indicate by check mark w |
|
| August 2, 2001 |
1 Exhibit 25.6 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-1 - STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) STATE STREET BANK AND TRUST COMPANY (Exact name of trustee as specified in its charter) Massachusetts 04-1867445 (J |
|
| August 2, 2001 |
1 EXHIBIT 4.51 AGREEMENT AS TO EXPENSES AND LIABILITIES AGREEMENT dated as of June 15, 2001, between Fresenius Medical Care AG, a corporation organized under the laws of Germany (the "Company"), and Fresenius Medical Care Capital Trust V, a Delaware business trust (the "Trust"). WHEREAS, the Trust intends to issue its Common Securities (the "Common Securities") to the Company and receive 7 3/8% Se |
|
| August 2, 2001 |
1 EXHIBIT 4.13 AMENDMENT NO. 11 THIS AMENDMENT NO. 11, dated as of May 31, 2001 (the "Amendment") relating to the Credit Agreement referenced below, by and among NATIONAL MEDICAL CARE, INC., a Delaware corporation, certain subsidiaries and affiliates party to the Credit Agreement and identified on the signature pages hereto, and BANK OF AMERICA, N.A., (formerly known as NationsBank, N.A), as Payin |
